Tibet Cheezheng Tibetan Medicine Co., Ltd. (SHE:002287)
China flag China · Delayed Price · Currency is CNY
19.86
-0.81 (-3.92%)
Aug 21, 2026, 3:04 PM CST

SHE:002287 Cash Flow Statement

Millions CNY. Fiscal year is Jan - Dec.

Operating Activities

Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Jun '26 Dec '25 Dec '24 Dec '23 Jan '23 Jan '22
Net Income
660.17648.43582.28581.2472.54715.88
Depreciation & Amortization
141.86141.75139.3493.2483.1965.83
Other Amortization
1.120.921.032.532.722.08
Loss (Gain) From Sale of Assets
-6.72-7.38--0.32-00.07
Asset Writedown & Restructuring Costs
-27.29-0.060.580.31.2216.13
Loss (Gain) From Sale of Investments
-26.22-68.09-100.32-69.3132.86-328.81
Provision & Write-off of Bad Debts
-0.4-0.740.160.380.74-1.36
Other Operating Activities
9.437.9457.8261.8454.948.66
Change in Accounts Receivable
-49.7212.29-278.7941.95-209.3369.7
Change in Inventory
-128.24-109.02-29.72-28.46-10.65-24.04
Change in Accounts Payable
-89.8280.7575.679.79-146.43136.6
Change in Other Net Operating Assets
0.28-0.06-24.5112.38-4.61
Operating Cash Flow
477.94729.7456.75693.41285.691,035
Operating Cash Flow Growth
-47.08%59.76%-34.13%142.72%-72.39%335.44%

Investing Activities

Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Jun '26 Dec '25 Dec '24 Dec '23 Jan '23 Jan '22
Capital Expenditures
-159.11-153.08-255.44-234.81-272.4-125.57
Sale of Property, Plant & Equipment
0.390.39-0.04-0
Cash Acquisitions
------61.11
Investment in Securities
160.7599.45-333.78-354.28-92.56-1,984
Other Investing Activities
57.8974.2371.21278.4730.4614.98
Investing Cash Flow
59.9320.99-518.02-310.59-334.5-2,155

Financing Activities

Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Jun '26 Dec '25 Dec '24 Dec '23 Jan '23 Jan '22
Long-Term Debt Issued
-961.58811.87750806.39500
Total Debt Issued
908.94961.58811.87750806.39500
Long-Term Debt Repaid
--936.36-667.63-961.85-645.26-347.38
Total Debt Repaid
-831.28-936.36-667.63-961.85-645.26-347.38
Net Debt Issued (Repaid)
77.6625.21144.24-211.85161.13152.62
Issuance of Common Stock
-----0.16
Repurchase of Common Stock
-78.52-137.45----
Common Dividends Paid
-571.37-453.04-282.45-220.05-340.51-195.54
Other Financing Activities
-3.641.2--0.6-3.84-
Financing Cash Flow
-575.87-564.08-138.21-432.5-183.22-42.76

Net Cash Flow

Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Jun '26 Dec '25 Dec '24 Dec '23 Jan '23 Jan '22
Foreign Exchange Rate Adjustments
-0.31-0.110.560.612.97-0.75
Net Cash Flow
-38.31186.5-198.91-49.07-229.06-1,164

Free Cash Flow

Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Jun '26 Dec '25 Dec '24 Dec '23 Jan '23 Jan '22
Free Cash Flow
318.83576.63201.31458.5913.29909.35
Free Cash Flow Growth
-58.90%186.44%-56.10%3350.89%-98.54%-
Free Cash Flow Margin
14.37%23.87%8.61%22.42%0.65%51.36%
Free Cash Flow Per Share
0.571.060.380.860.031.72
Levered Free Cash Flow
-150220.17-157.58457.62-2.83576.99
Unlevered Free Cash Flow
-142.23246.33-121.46497.0432.43610.38

Additional Metrics

Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Jun '26 Dec '25 Dec '24 Dec '23 Jan '23 Jan '22
Cash Income Tax Paid
355.32354.49333.34284.33243.7270.37
Change in Working Capital
-273.98-23.05-224.1423.54-362.48516.45